CPHI Expands to Serve Russias Rapidly Growing Pharma Market
AMSTERDAM, 9 October 2012 — Leading event organiser, UBM Live, today announced the launch of CPHI Russia at IPhEB as the latest expansion of its global pharmaceutical events. UBM Live actively sought a partnership with RESTEC, respected Russian organiser of IPhEB, the St. Petersburg International Forum for Pharmacy, Medical Equipment, Biotechnology and Radiology to facilitate access to the Russian market. The events will bring together the senior Russian pharma professionals who attend IPhEB with the global pharmaceutical suppliers and buyers who attend CPHI. The events will be co-located and held on April 10 -11, 2013 in Manege Central Exhibition Hall in St. Petersburg.
The Russian pharmaceutical market experienced high double-digit growth in recent years and is positioned firmly at the forefront of pharmerging markets. Russia is currently the eleventh largest pharmaceutical market in the world and is projected to reach a value of US $26.7 billion by the end of 2013. The Russian Government's ambitious Pharma 2020 plan, introduced in 2009, includes funding of nearly US$5 billion and seeks to dramatically increase domestic pharmaceutical manufacturing and R&D capabilities. As a result of the Pharma 2020 plan the demand for pharmaceutical ingredients and manufacturing and packaging equipment will be increasing dramatically in order to upgrade existing manufacturing sites to GMP standards.
“The Russian pharmaceutical market is set for tremendous growth: this year we already have seen leading pharmaceutical companies, such as Novartis and AstraZeneca, opening manufacturing sites and R&D centres in the St. Petersburg region and other parts of Russia. We believe our industry leading face-to-face events and digital products can play a critical role in accelerating that growth and driving innovation in the Russian pharmaceutical market,” noted Andrew Pert, Brand Director for CPHI Russia.
UBM Live’s survey results from visitors to the Frankfurt CPHI Worldwide event in 2011 showed that 42 percent of attendees were already actively working in the Russian pharmaceutical market, and more than one third had plans to enter the market over the next two years.
“We feel that this is the right time to introduce a top-level networking event that can help to facilitate successful entry into this market for our customer base and are delighted to collocate with the well established IPhEB Forum,” added Pert. In 2012 the event was strongly supported by the national government, including support from The Ministry of Industry and Trade of the Russian Federation, The Chamber of Commerce and Industry of the Russian Federation, St. Petersburg City Administration and the Committee for Economic Development, Industrial Policy and Trade.
Bringing CPHI to Russia is a logical next step after the debut of a dedicated Russian Pavilion at CPHI Worldwide 2012 with support from the Ministry of Industry and Trade of the Russian Federation. CPHI Worldwide will also host high profile exhibitors from Russia, including Indukern-Rus, R&D Pharma, P & M Invest, INVAR and Dalchem.
To learn more about CPHI Russia at IPhEB, please visit www.cphi-russia.com.
The annual UBM Live Pharma Portfolio of events also includes CPHI Worldwide, ICSE, P-MEC Europe and InnoPack (9-11 October, 2012 at the Feria de Madrid in Spain); CPHI, ICSE, P-MEC India and BioPh (21-23 November, 2012 at the Bombay Exhibition Centre in Mumbai); CPHI, P-MEC, InnoPack South East Asia (20-22 March, 2013 at the Jakarta International Expo in Indonesia); CPHI, ICSE, P-MEC, BioPh and Pharmatec Japan (24-26 April, 2013 at the Tokyo Big Sight Exhibition Centre in Japan); CPHI, P-MEC, ICSE, InnoPack, LABWorld, BioPh China (25-27 June 2013 at the SNIEC in Shanghai); and CPHI South America (6-8 August 2013 at the Expo Centre Norte, Sao Paulo, Brazil).
About UBM Live:
UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.
About RESTEC® Exhibition Company:
RESTEC® Exhibition Company is one of the top three leaders of the Russia`s exhibition business. The optimal structure formed by RESTEC® let us combine exhibition, congress, business and contest programs that altogether foster effective work of our exhibitors, participants, delegates and trade visitors. At this point our exhibition and congress events continue developing as centers of international business networking with the constantly growing number of countries and participants represented. For more information, go to www.restec.ru/en.
Related News
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease. -
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance